1. Home
  2. CATX vs NXP Comparison

CATX vs NXP Comparison

Compare CATX & NXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CATX
  • NXP
  • Stock Information
  • Founded
  • CATX 1983
  • NXP 1992
  • Country
  • CATX United States
  • NXP United States
  • Employees
  • CATX N/A
  • NXP N/A
  • Industry
  • CATX Medical/Dental Instruments
  • NXP Trusts Except Educational Religious and Charitable
  • Sector
  • CATX Health Care
  • NXP Finance
  • Exchange
  • CATX Nasdaq
  • NXP Nasdaq
  • Market Cap
  • CATX 782.7M
  • NXP 730.9M
  • IPO Year
  • CATX N/A
  • NXP N/A
  • Fundamental
  • Price
  • CATX $3.44
  • NXP $14.79
  • Analyst Decision
  • CATX Strong Buy
  • NXP
  • Analyst Count
  • CATX 9
  • NXP 0
  • Target Price
  • CATX $17.25
  • NXP N/A
  • AVG Volume (30 Days)
  • CATX 1.2M
  • NXP 70.0K
  • Earning Date
  • CATX 02-12-2025
  • NXP 01-01-0001
  • Dividend Yield
  • CATX N/A
  • NXP 4.04%
  • EPS Growth
  • CATX N/A
  • NXP N/A
  • EPS
  • CATX N/A
  • NXP 0.54
  • Revenue
  • CATX $1,557,000.00
  • NXP N/A
  • Revenue This Year
  • CATX N/A
  • NXP N/A
  • Revenue Next Year
  • CATX N/A
  • NXP N/A
  • P/E Ratio
  • CATX N/A
  • NXP $26.81
  • Revenue Growth
  • CATX N/A
  • NXP N/A
  • 52 Week Low
  • CATX $2.70
  • NXP $12.91
  • 52 Week High
  • CATX $19.10
  • NXP $14.89
  • Technical
  • Relative Strength Index (RSI)
  • CATX 41.92
  • NXP 47.10
  • Support Level
  • CATX $3.02
  • NXP $14.75
  • Resistance Level
  • CATX $3.74
  • NXP $14.88
  • Average True Range (ATR)
  • CATX 0.26
  • NXP 0.18
  • MACD
  • CATX 0.16
  • NXP -0.02
  • Stochastic Oscillator
  • CATX 60.90
  • NXP 19.61

About CATX Perspective Therapeutics Inc.

Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.

About NXP Nuveen Select Tax Free Income Portfolio

Nuveen Select Tax Free Income Portfolio is a diversified closed-end investment company. It seeks to provide current income and stable dividends, exempt from regular federal and designated state income taxes, consistent with the preservation of capital by investing primarily in a portfolio of municipal obligations.

Share on Social Networks: